MKI67 and neoplasm: Higher immunostaining for Ki-67 is observed in malignant mammary neoplasms and is correlated with lower hormonal receptor expression, a higher tumor histological grade, a larger tumor size, the presence of metastases, and shorter survival times in both female dogs and cats [59,93].